4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
16.76
+2.04 (13.86%)
At close: Aug 19, 2026, 4:00 PM EDT
16.68
-0.08 (-0.48%)
After-hours: Aug 19, 2026, 7:55 PM EDT
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $925.89 million as of August 19, 2026. Its market cap has increased by 172.70% in one year.
Market Cap
925.89M
Enterprise Value
534.48M
1-Year Change
172.70%
Ranking
Category
Stock Price
$16.76
ChartMarket Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has increased from $580.38M to $925.89M, an increase of 59.53%. That is a compound annual growth rate of 8.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 925.89M | 116.07% |
| Dec 31, 2025 | 428.51M | 66.42% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SpyGlass Pharma | 864.30M |
| Faeth Therapeutics | 852.73M |
| Silence Therapeutics | 848.95M |
| Aura Biosciences | 846.23M |
| Immix Biopharma | 844.88M |
| Rigel Pharmaceuticals | 814.82M |
| Bright Minds Biosciences | 814.40M |
| Oculis Holding AG | 814.25M |